Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
Jose Maria Ruiz-MorenoLuís AriasMaximino J AbraldesJavier MonteroPatricia Udaondonull nullPublished in: International ophthalmology (2021)
AMD was associated with considerable healthcare costs for regional healthcare systems. Diagnostic examinations, particularly OCT examinations, and anti-VEGF treatment represented the largest cost items.